Single-source drug launches in GLOBE/GUARD European reference markets fall 27% in first 17 months since MFN EO, reveals GlobalData
Some 27% fewer new pharmaceutical active ingredients (i.e. new single-source brands) were launched in the European reference markets under the GLOBE and GUARD MF...



















